Literature DB >> 15129170

Multidrug resistance protein 1-mediated transport of saquinavir by microglia.

Shannon Dallas1, Patrick T Ronaldson, Moise Bendayan, Reina Bendayan.   

Abstract

Regulation of CNS distribution of the human immunodeficiency virus (HIV) protease inhibitor saquinavir may involve ATP-dependent membrane-bound efflux transport proteins that are expressed in several brain cellular compartments. We recently characterized molecular and functional expression of one such transporter, multidrug resistance protein-1 (MRP1) in microglia, the primary brain cellular target of HIV. In the present study, we further examine subcellular localization of MRP1 in a microglia cell line (MLS-9) using immunogold cytochemistry and directly demonstrate MRP1-mediated export of saquinavir. MRP1 localized primarily to the plasma membrane of the MLS-9 cells. [14C]Saquinavir efflux by MLS-9 monolayers was inhibited by well-established MRP1 inhibitors. These results indicate that MRP1 contributes, in part, to the overall low permeation of protease inhibitors in the brain. Copyright 2004 Lippincott Williams and Wilkins

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15129170     DOI: 10.1097/00001756-200405190-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes.

Authors:  Tamima Ashraf; Patrick T Ronaldson; Yuri Persidsky; Reina Bendayan
Journal:  J Neurosci Res       Date:  2011-08-08       Impact factor: 4.164

4.  Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.

Authors:  Florian Rothweiler; Martin Michaelis; Peter Brauer; Jürgen Otte; Kristoffer Weber; Boris Fehse; Hans Wilhelm Doerr; Michael Wiese; Jörg Kreuter; Yousef Al-Abed; Ferdinando Nicoletti; Jindrich Cinatl
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

5.  Multidrug transporter activity in lymphocytes.

Authors:  James I Elliott; Selina Raguz; Christopher F Higgins
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

Review 6.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

7.  Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophages.

Authors:  Peter S Silverstein; Kenneth L Audus; Nilofer Qureshi; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-06       Impact factor: 4.147

Review 8.  Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy.

Authors:  Kathleen Köck; Markus Grube; Gabriele Jedlitschky; Lena Oevermann; Werner Siegmund; Christoph A Ritter; Heyo K Kroemer
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment.

Authors:  Shannon Dallas; Michelle L Block; Deborah M Thompson; Marcelo G Bonini; Patrick T Ronaldson; Reina Bendayan; David S Miller
Journal:  J Neuroinflammation       Date:  2013-05-04       Impact factor: 8.322

10.  Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals.

Authors:  Tozammel M D Hoque; Amélie Cattin; Sana-Kay Whyte-Allman; Lee Winchester; Courtney V Fletcher; Jean-Pierre Routy; Petronela Ancuta; Reina Bendayan
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.